-
3
-
-
79960364043
-
Hepatocellular cancer in the non-cirrhotic liver
-
Alkofer B, Lepennec V, Chiche L. Hepatocellular cancer in the non-cirrhotic liver. J Visc Surg 2011; 148: 3-11.
-
(2011)
J Visc Surg
, vol.148
, pp. 3-11
-
-
Alkofer, B.1
Lepennec, V.2
Chiche, L.3
-
4
-
-
79959296814
-
The global epidemiology of hepatocellular carcinoma: present and future
-
McGlynn KA, London WT. The global epidemiology of hepatocellular carcinoma: present and future. Clin Liver Dis 2011; 15: 223-243.
-
(2011)
Clin Liver Dis
, vol.15
, pp. 223-243
-
-
McGlynn, K.A.1
London, W.T.2
-
5
-
-
34250020201
-
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis
-
El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-2576.
-
(2007)
Gastroenterology
, vol.132
, pp. 2557-2576
-
-
El-Serag, H.B.1
Rudolph, K.L.2
-
8
-
-
64749107607
-
RAGE (receptor for advanced glycation endproducts), RAGE ligands, and their role in cancer and inflammation
-
Sparvero LJ, Asafu-Adjei D, Kang R, Tang D, Amin N, Im J, et al. RAGE (receptor for advanced glycation endproducts), RAGE ligands, and their role in cancer and inflammation. J Transl Med 2009; 7: 17.
-
(2009)
J Transl Med
, vol.7
, pp. 17
-
-
Sparvero, L.J.1
Asafu-Adjei, D.2
Kang, R.3
Tang, D.4
Amin, N.5
Im, J.6
-
9
-
-
44449097168
-
AGE-RAGE system and carcinogenesis
-
Abe R, Yamagishi S. AGE-RAGE system and carcinogenesis. Curr Pharm Des 2008; 14: 940-945.
-
(2008)
Curr Pharm Des
, vol.14
, pp. 940-945
-
-
Abe, R.1
Yamagishi, S.2
-
10
-
-
77953061313
-
Advanced glycation end products in foods and a practical guide to their reduction in the diet
-
Uribarri J, Woodruff S, Goodman S, Cai W, Chen X, Pyzik R, et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc 2010; 110: 911-916.
-
(2010)
J Am Diet Assoc
, vol.110
, pp. 911-916
-
-
Uribarri, J.1
Woodruff, S.2
Goodman, S.3
Cai, W.4
Chen, X.5
Pyzik, R.6
-
11
-
-
77955867860
-
Does accumulation of advanced glycation end products contribute to the aging phenotype?
-
Semba RD, Nicklett EJ, Ferrucci L. Does accumulation of advanced glycation end products contribute to the aging phenotype? J Gerontol A Biol Sci Med Sci 2010; 65: 963-975.
-
(2010)
J Gerontol A Biol Sci Med Sci
, vol.65
, pp. 963-975
-
-
Semba, R.D.1
Nicklett, E.J.2
Ferrucci, L.3
-
12
-
-
84855496808
-
Dietary intake associated with serum versus urinary carboxymethyl-lysine, a major advanced glycation end product, in adults: the Energetics Study
-
Semba RD, Ang A, Talegawkar S, Crasto C, Dalal M, Jardack P, et al. Dietary intake associated with serum versus urinary carboxymethyl-lysine, a major advanced glycation end product, in adults: the Energetics Study. Eur J Clin Nutr 2012; 66: 3-9.
-
(2012)
Eur J Clin Nutr
, vol.66
, pp. 3-9
-
-
Semba, R.D.1
Ang, A.2
Talegawkar, S.3
Crasto, C.4
Dalal, M.5
Jardack, P.6
-
13
-
-
44449166649
-
Advanced glycation end products (AGEs) and their involvement in liver disease
-
Hyogo H, Yamagishi S. Advanced glycation end products (AGEs) and their involvement in liver disease. Curr Pharm Des 2008; 14: 969-972.
-
(2008)
Curr Pharm Des
, vol.14
, pp. 969-972
-
-
Hyogo, H.1
Yamagishi, S.2
-
14
-
-
70349859675
-
Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications
-
Bierhaus A, Nawroth PP. Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications. Diabetologia 2009; 52: 2251-2263.
-
(2009)
Diabetologia
, vol.52
, pp. 2251-2263
-
-
Bierhaus, A.1
Nawroth, P.P.2
-
15
-
-
79957748972
-
What is the role of the receptor for advanced glycation end products-ligand axis in liver injury?
-
Basta G, Navarra T, De Simone P, Del Turco S, Gastaldelli A, Filipponi F. What is the role of the receptor for advanced glycation end products-ligand axis in liver injury? Liver Transpl 2011; 17: 633-640.
-
(2011)
Liver Transpl
, vol.17
, pp. 633-640
-
-
Basta, G.1
Navarra, T.2
De Simone, P.3
Del Turco, S.4
Gastaldelli, A.5
Filipponi, F.6
-
16
-
-
39149118886
-
A novel function of the receptor for advanced glycation end-products (RAGE) in association with tumorigenesis and tumor differentiation of HCC
-
Hiwatashi K, Ueno S, Abeyama K, Kubo F, Sakoda M, Maruyama I, et al. A novel function of the receptor for advanced glycation end-products (RAGE) in association with tumorigenesis and tumor differentiation of HCC. Ann Surg Oncol 2008; 15: 923-933.
-
(2008)
Ann Surg Oncol
, vol.15
, pp. 923-933
-
-
Hiwatashi, K.1
Ueno, S.2
Abeyama, K.3
Kubo, F.4
Sakoda, M.5
Maruyama, I.6
-
17
-
-
29344443061
-
Elevation of Nepsilon-(carboxymethyl)lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosis
-
Yagmur E, Tacke F, Weiss C, Lahme B, Manns MP, Kiefer P, et al. Elevation of Nepsilon-(carboxymethyl)lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosis. Clin Biochem 2006; 39: 39-45.
-
(2006)
Clin Biochem
, vol.39
, pp. 39-45
-
-
Yagmur, E.1
Tacke, F.2
Weiss, C.3
Lahme, B.4
Manns, M.P.5
Kiefer, P.6
-
18
-
-
34347394798
-
Elevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitis
-
Hyogo H, Yamagishi S, Iwamoto K, Arihiro K, Takeuchi M, Sato T, et al. Elevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitis. J Gastroenterol Hepatol 2007; 22: 1112-1119.
-
(2007)
J Gastroenterol Hepatol
, vol.22
, pp. 1112-1119
-
-
Hyogo, H.1
Yamagishi, S.2
Iwamoto, K.3
Arihiro, K.4
Takeuchi, M.5
Sato, T.6
-
19
-
-
54049108485
-
A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)
-
Raucci A, Cugusi S, Antonelli A, Barabino SM, Monti L, Bierhaus A, et al. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J 2008; 22: 3716-3727.
-
(2008)
FASEB J
, vol.22
, pp. 3716-3727
-
-
Raucci, A.1
Cugusi, S.2
Antonelli, A.3
Barabino, S.M.4
Monti, L.5
Bierhaus, A.6
-
20
-
-
0037444761
-
Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury
-
Yonekura H, Yamamoto Y, Sakurai S, Petrova RG, Abedin MJ, Li H, et al. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J 2003; 370: 1097-1109.
-
(2003)
Biochem J
, vol.370
, pp. 1097-1109
-
-
Yonekura, H.1
Yamamoto, Y.2
Sakurai, S.3
Petrova, R.G.4
Abedin, M.J.5
Li, H.6
-
21
-
-
34447622625
-
Unchanged serum levels of advanced glycation endproducts in patients with liver disease
-
Butscheid M, Schafer C, Brenner S, Alscher D, Murdter T, Niwa T, et al. Unchanged serum levels of advanced glycation endproducts in patients with liver disease. Naunyn Schmiedebergs Arch Pharmacol 2007; 375: 401-406.
-
(2007)
Naunyn Schmiedebergs Arch Pharmacol
, vol.375
, pp. 401-406
-
-
Butscheid, M.1
Schafer, C.2
Brenner, S.3
Alscher, D.4
Murdter, T.5
Niwa, T.6
-
22
-
-
34247132569
-
Hepatic expression of galectin-3 and receptor for advanced glycation end products in patients with liver disease
-
Butscheid M, Hauptvogel P, Fritz P, Klotz U, Alscher DM. Hepatic expression of galectin-3 and receptor for advanced glycation end products in patients with liver disease. J Clin Pathol 2007; 60: 415-418.
-
(2007)
J Clin Pathol
, vol.60
, pp. 415-418
-
-
Butscheid, M.1
Hauptvogel, P.2
Fritz, P.3
Klotz, U.4
Alscher, D.M.5
-
23
-
-
13644264763
-
RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB
-
Cataldegirmen G, Zeng S, Feirt N, Ippagunta N, Dun H, Qu W, et al. RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB. J Exp Med 2005; 201: 473-484.
-
(2005)
J Exp Med
, vol.201
, pp. 473-484
-
-
Cataldegirmen, G.1
Zeng, S.2
Feirt, N.3
Ippagunta, N.4
Dun, H.5
Qu, W.6
-
24
-
-
33645892294
-
Blockade of the receptor for advanced glycation end products attenuates acetaminophen-induced hepatotoxicity in mice
-
Ekong U, Zeng S, Dun H, Feirt N, Guo J, Ippagunta N, et al. Blockade of the receptor for advanced glycation end products attenuates acetaminophen-induced hepatotoxicity in mice. J Gastroenterol Hepatol 2006; 21: 682-688.
-
(2006)
J Gastroenterol Hepatol
, vol.21
, pp. 682-688
-
-
Ekong, U.1
Zeng, S.2
Dun, H.3
Feirt, N.4
Guo, J.5
Ippagunta, N.6
-
25
-
-
0036126560
-
Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis-amelioration by liver transplantation
-
Sebekova K, Kupcova V, Schinzel R, Heidland A. Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis-amelioration by liver transplantation. J Hepatol 2002; 36: 66-71.
-
(2002)
J Hepatol
, vol.36
, pp. 66-71
-
-
Sebekova, K.1
Kupcova, V.2
Schinzel, R.3
Heidland, A.4
-
26
-
-
67349263467
-
Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease
-
Yilmaz Y, Ulukaya E, Gul OO, Arabul M, Gul CB, Atug O, et al. Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease. Clin Biochem 2009; 42: 802-807.
-
(2009)
Clin Biochem
, vol.42
, pp. 802-807
-
-
Yilmaz, Y.1
Ulukaya, E.2
Gul, O.O.3
Arabul, M.4
Gul, C.B.5
Atug, O.6
-
27
-
-
10744229479
-
Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice
-
Zeng S, Feirt N, Goldstein M, Guarrera J, Ippagunta N, Ekong U, et al. Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice. HEPATOLOGY 2004; 39: 422-432.
-
(2004)
HEPATOLOGY
, vol.39
, pp. 422-432
-
-
Zeng, S.1
Feirt, N.2
Goldstein, M.3
Guarrera, J.4
Ippagunta, N.5
Ekong, U.6
-
28
-
-
36849057047
-
Receptor for advanced glycation end products (RAGE)-soluble form (sRAGE) and gene polymorphisms in patients with breast cancer
-
Tesarova P, Kalousova M, Jachymova M, Mestek O, Petruzelka L, Zima T. Receptor for advanced glycation end products (RAGE)-soluble form (sRAGE) and gene polymorphisms in patients with breast cancer. Cancer Invest 2007; 25: 720-725.
-
(2007)
Cancer Invest
, vol.25
, pp. 720-725
-
-
Tesarova, P.1
Kalousova, M.2
Jachymova, M.3
Mestek, O.4
Petruzelka, L.5
Zima, T.6
-
29
-
-
77953716356
-
Soluble receptor for advanced glycation end-products (sRAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer
-
Krechler T, Jachymova M, Mestek O, Zak A, Zima T, Kalousova M. Soluble receptor for advanced glycation end-products (sRAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer. Clin Biochem 2010; 43: 882-886.
-
(2010)
Clin Biochem
, vol.43
, pp. 882-886
-
-
Krechler, T.1
Jachymova, M.2
Mestek, O.3
Zak, A.4
Zima, T.5
Kalousova, M.6
-
30
-
-
77953638811
-
Receptor for advanced glycation end products (RAGE) soluble form (sRAGE): a new biomarker for lung cancer
-
Jing R, Cui M, Wang J, Wang H. Receptor for advanced glycation end products (RAGE) soluble form (sRAGE): a new biomarker for lung cancer. Neoplasma 2010; 57: 55-61.
-
(2010)
Neoplasma
, vol.57
, pp. 55-61
-
-
Jing, R.1
Cui, M.2
Wang, J.3
Wang, H.4
-
31
-
-
84859388699
-
The associations of advanced glycation end products and its soluble receptor with pancreatic cancer risk: a case-control study within the prospective EPIC cohort
-
Grote VA, Nieters A, Kaaks R, Tjonneland A, Roswall N, Overvad K, et al. The associations of advanced glycation end products and its soluble receptor with pancreatic cancer risk: a case-control study within the prospective EPIC cohort. Cancer Epidemiol Biomarkers Prev 2012; 21: 619-628.
-
(2012)
Cancer Epidemiol Biomarkers Prev
, vol.21
, pp. 619-628
-
-
Grote, V.A.1
Nieters, A.2
Kaaks, R.3
Tjonneland, A.4
Roswall, N.5
Overvad, K.6
-
32
-
-
79956159720
-
Evidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective study
-
Jiao L, Weinstein SJ, Albanes D, Taylor PR, Graubard BI, Virtamo J, et al. Evidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective study. Cancer Res 2011; 71: 3582-3589.
-
(2011)
Cancer Res
, vol.71
, pp. 3582-3589
-
-
Jiao, L.1
Weinstein, S.J.2
Albanes, D.3
Taylor, P.R.4
Graubard, B.I.5
Virtamo, J.6
-
33
-
-
79960107261
-
Advanced glycation end products, soluble receptor for advanced glycation end products, and risk of colorectal cancer
-
Jiao L, Taylor PR, Weinstein SJ, Graubard BI, Virtamo J, Albanes D, et al. Advanced glycation end products, soluble receptor for advanced glycation end products, and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2011; 20: 1430-1438.
-
(2011)
Cancer Epidemiol Biomarkers Prev
, vol.20
, pp. 1430-1438
-
-
Jiao, L.1
Taylor, P.R.2
Weinstein, S.J.3
Graubard, B.I.4
Virtamo, J.5
Albanes, D.6
-
34
-
-
0028120012
-
The ATBC Cancer Prevention Study Group
-
The alpha-tocopherol beta-carotene lung cancer prevention study, participant characteristics and compliance, designmethods
-
The alpha-tocopherol, beta-carotene lung cancer prevention study, designmethods participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. Ann Epidemiol 1994; 4: 1-10.
-
(1994)
Ann Epidemiol
, vol.4
, pp. 1-10
-
-
-
35
-
-
0036352741
-
The Finnish Cancer Registry as follow-up source of a large trial cohort-accuracy and delay
-
Korhonen P, Malila N, Pukkala E, Teppo L, Albanes D, Virtamo J. The Finnish Cancer Registry as follow-up source of a large trial cohort-accuracy and delay. Acta Oncol 2002; 41: 381-388.
-
(2002)
Acta Oncol
, vol.41
, pp. 381-388
-
-
Korhonen, P.1
Malila, N.2
Pukkala, E.3
Teppo, L.4
Albanes, D.5
Virtamo, J.6
-
36
-
-
4544341580
-
Elevated serum levels of N(epsilon)-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema
-
Boehm BO, Schilling S, Rosinger S, Lang GE, Lang GK, Kientsch-Engel R, et al. Elevated serum levels of N(epsilon)-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema. Diabetologia 2004; 47: 1376-1379.
-
(2004)
Diabetologia
, vol.47
, pp. 1376-1379
-
-
Boehm, B.O.1
Schilling, S.2
Rosinger, S.3
Lang, G.E.4
Lang, G.K.5
Kientsch-Engel, R.6
-
37
-
-
33845323430
-
Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers
-
Limburg PJ, Stolzenberg-Solomon RZ, Vierkant RA, Roberts K, Sellers TA, Taylor PR, et al. Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers. Clin Gastroenterol Hepatol 2006; 4: 1514-1521.
-
(2006)
Clin Gastroenterol Hepatol
, vol.4
, pp. 1514-1521
-
-
Limburg, P.J.1
Stolzenberg-Solomon, R.Z.2
Vierkant, R.A.3
Roberts, K.4
Sellers, T.A.5
Taylor, P.R.6
-
38
-
-
0033560104
-
Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements
-
Hu FB, Stampfer MJ, Rimm E, Ascherio A, Rosner BA, Spiegelman D, et al. Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol 1999; 149: 531-540.
-
(1999)
Am J Epidemiol
, vol.149
, pp. 531-540
-
-
Hu, F.B.1
Stampfer, M.J.2
Rimm, E.3
Ascherio, A.4
Rosner, B.A.5
Spiegelman, D.6
-
40
-
-
79951908002
-
What is the significance of soluble and endogenous secretory receptor for advanced glycation end products in liver steatosis in obese prepubertal children?
-
D'Adamo E, Giannini C, Chiavaroli V, de Giorgis T, Verrotti A, Chiarelli F, et al. What is the significance of soluble and endogenous secretory receptor for advanced glycation end products in liver steatosis in obese prepubertal children? Antioxid Redox Signal 2011; 14: 1167-1172.
-
(2011)
Antioxid Redox Signal
, vol.14
, pp. 1167-1172
-
-
D'Adamo, E.1
Giannini, C.2
Chiavaroli, V.3
de Giorgis, T.4
Verrotti, A.5
Chiarelli, F.6
-
41
-
-
78650081462
-
Is HMGB1 a new indirect marker for revealing fibrosis in chronic hepatitis and a new therapeutic target in treatment?
-
Albayrak A, Uyanik MH, Cerrah S, Altas S, Dursun H, Demir M, et al. Is HMGB1 a new indirect marker for revealing fibrosis in chronic hepatitis and a new therapeutic target in treatment? Viral Immunol 2010; 23: 633-638.
-
(2010)
Viral Immunol
, vol.23
, pp. 633-638
-
-
Albayrak, A.1
Uyanik, M.H.2
Cerrah, S.3
Altas, S.4
Dursun, H.5
Demir, M.6
-
42
-
-
80052599568
-
Fat mass is inversely associated with serum carboxymethyl-lysine, an advanced glycation end product, in adults
-
Semba RD, Arab L, Sun K, Nicklett EJ, Ferrucci L. Fat mass is inversely associated with serum carboxymethyl-lysine, an advanced glycation end product, in adults. J Nutr 2011; 141: 1726-1730.
-
(2011)
J Nutr
, vol.141
, pp. 1726-1730
-
-
Semba, R.D.1
Arab, L.2
Sun, K.3
Nicklett, E.J.4
Ferrucci, L.5
-
43
-
-
0036569559
-
Prospective study of diet and pancreatic cancer in male smokers
-
Stolzenberg-Solomon RZ, Pietinen P, Taylor PR, Virtamo J, Albanes D. Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol 2002; 155: 783-792.
-
(2002)
Am J Epidemiol
, vol.155
, pp. 783-792
-
-
Stolzenberg-Solomon, R.Z.1
Pietinen, P.2
Taylor, P.R.3
Virtamo, J.4
Albanes, D.5
-
44
-
-
67650809081
-
Dietary fatty acids and pancreatic cancer in the NIH-AARP diet and health study
-
Thiebaut AC, Jiao L, Silverman DT, Cross AJ, Thompson FE, Subar AF, et al. Dietary fatty acids and pancreatic cancer in the NIH-AARP diet and health study. J Natl Cancer Inst 2009; 101: 1001-1011.
-
(2009)
J Natl Cancer Inst
, vol.101
, pp. 1001-1011
-
-
Thiebaut, A.C.1
Jiao, L.2
Silverman, D.T.3
Cross, A.J.4
Thompson, F.E.5
Subar, A.F.6
-
45
-
-
0003171299
-
Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium
-
Global surveillance and control of hepatitis C
-
Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 1999; 6: 35-47.
-
(1999)
J Viral Hepat
, vol.6
, pp. 35-47
-
-
|